Page last updated: 2024-10-18

hydroquinone and Tuberous Sclerosis

hydroquinone has been researched along with Tuberous Sclerosis in 1 studies

Tuberous Sclerosis: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.

Research Excerpts

ExcerptRelevanceReference
"In patients with tuberous sclerosis complex (TSC), a wide range of neurologic abnormalities develop, including mental retardation and seizures."1.32Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex. ( Baraban, SC; Barbaro, NM; Dinday, MT; Takahashi, DK, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahashi, DK1
Dinday, MT1
Barbaro, NM1
Baraban, SC1

Other Studies

1 other study available for hydroquinone and Tuberous Sclerosis

ArticleYear
Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex.
    Epilepsia, 2004, Volume: 45, Issue:12

    Topics: Animals; Astrocytoma; Brain Neoplasms; Cerebral Cortex; Disease Models, Animal; Female; Hydroquinone

2004